<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T07:17:46Z</responseDate>
  <request identifier="oai:figshare.com:article/33791459" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33791459</identifier>
        <datestamp>2026-09-15T12:10:23Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Comparing Suspect
and Nontargeted Screening Workflows
for Perinatal Chemical Exposome Analysis: A European Interlaboratory
Study from the PARC-EU Project</dc:title>
          <dc:creator>Tarek Moufawad (6424937)</dc:creator>
          <dc:creator>Kolawole Ayeni (24931991)</dc:creator>
          <dc:creator>Eirini Baira (13134882)</dc:creator>
          <dc:creator>Christian Baudry (24931994)</dc:creator>
          <dc:creator>Lidia Belova (10588277)</dc:creator>
          <dc:creator>Jade Chaker (9910372)</dc:creator>
          <dc:creator>Clement Chalet (24931997)</dc:creator>
          <dc:creator>Adrian Covaci (508263)</dc:creator>
          <dc:creator>Annelaure Damont (1523899)</dc:creator>
          <dc:creator>Arthur David (1497043)</dc:creator>
          <dc:creator>Mariana F. Fernandez (9516363)</dc:creator>
          <dc:creator>Baninia Habchi (17014838)</dc:creator>
          <dc:creator>Carolin Huber (11015471)</dc:creator>
          <dc:creator>Gaëlle Jadé (24932000)</dc:creator>
          <dc:creator>Tina Kosjek (2356276)</dc:creator>
          <dc:creator>Martin Krauss (763813)</dc:creator>
          <dc:creator>Michel Laurentie (486517)</dc:creator>
          <dc:creator>Sophie Ndaw (24932003)</dc:creator>
          <dc:creator>Rosalie Nijssen (11784352)</dc:creator>
          <dc:creator>Herbert Oberacher (148628)</dc:creator>
          <dc:creator>Helena Plesnik (24932006)</dc:creator>
          <dc:creator>Zan Rekar (24932009)</dc:creator>
          <dc:creator>Serena Rizzo (21534923)</dc:creator>
          <dc:creator>Elena Salamanca-Fernandez (14393913)</dc:creator>
          <dc:creator>Aikaterini Termentzi (127084)</dc:creator>
          <dc:creator>Katrin Vorkamp (611059)</dc:creator>
          <dc:creator>Benedikt Warth (2012569)</dc:creator>
          <dc:creator>Linyan Zhu (3114861)</dc:creator>
          <dc:creator>Konstantinos M. Kasiotis (3684907)</dc:creator>
          <dc:creator>Bruno Le Bizec (8615598)</dc:creator>
          <dc:creator>Marja Lamoree (71796)</dc:creator>
          <dc:creator>Jean-Philippe Antignac (694876)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>varying polarities spiked</dc:subject>
          <dc:subject>resolution mass spectrometry</dc:subject>
          <dc:subject>european interlaboratory study</dc:subject>
          <dc:subject>eu project early</dc:subject>
          <dc:subject>0 – 6</dc:subject>
          <dc:subject>comprehensive exposure characterization</dc:subject>
          <dc:subject>nontargeted screening workflows</dc:subject>
          <dc:subject>hrms covering compounds</dc:subject>
          <dc:subject>nontargeted screening</dc:subject>
          <dc:subject>comprehensive assessments</dc:subject>
          <dc:subject>50 compounds</dc:subject>
          <dc:subject>workflows provides</dc:subject>
          <dc:subject>different workflows</dc:subject>
          <dc:subject>workflow performances</dc:subject>
          <dc:subject>three techniques</dc:subject>
          <dc:subject>three concentrations</dc:subject>
          <dc:subject>shared list</dc:subject>
          <dc:subject>risk assessments</dc:subject>
          <dc:subject>qc provisions</dc:subject>
          <dc:subject>powerful framework</dc:subject>
          <dc:subject>participants used</dc:subject>
          <dc:subject>p &lt;/</dc:subject>
          <dc:subject>multivariable analyses</dc:subject>
          <dc:subject>maternal urine</dc:subject>
          <dc:subject>limited subset</dc:subject>
          <dc:subject>house methods</dc:subject>
          <dc:subject>harmonized qa</dc:subject>
          <dc:subject>gas chromatography</dc:subject>
          <dc:subject>findings demonstrate</dc:subject>
          <dc:subject>extending chemical</dc:subject>
          <dc:subject>exposure data</dc:subject>
          <dc:subject>environmental contaminants</dc:subject>
          <dc:subject>emerging chemicals</dc:subject>
          <dc:subject>chemical exposureome</dc:subject>
          <dc:subject>broad range</dc:subject>
          <dc:subject>additionally benchmarked</dc:subject>
          <dc:subject>added value</dc:subject>
          <dc:description>Early-life chemical exposures may contribute to adverse
health
outcomes later in life. However, conventional chemical analyses typically
cover only a limited subset of the chemical exposureome. Suspect and
nontargeted screening (SS/NTS) using high-resolution mass spectrometry
(HRMS) workflows provides a powerful framework for comprehensive assessments
of exposure, with the potential to detect a broad range of environmental
contaminants and emerging chemicals. An interlaboratory assay involving
12 laboratories was performed to evaluate the comparability and complementarity
of SS/NTS approaches for maternal urine, serum, and milk, based on
reversed-phase (RPLC), hydrophilic interaction liquid chromatography
(HILIC), and gas chromatography (GC) with HRMS. Participants used
in-house methods to possibly detect a predefined and shared list of
50 compounds with varying polarities spiked at three concentrations.
The overall detection rates ranged from 4% to 72% for all three techniques,
with RPLC-HRMS covering compounds with log &lt;i&gt;P&lt;/i&gt; 0–6, while HILIC-HRMS and GC-HRMS  extended this coverage.
Univariate and multivariable analyses of RPLC-HRMS results for serum
and urine identified sample preparation steps as key factors influencing
detection rates. Workflow performances were additionally benchmarked
by using the S-score. These findings demonstrate the complementarity
of SS/NTS platforms for extending chemical-space coverage for the
most comprehensive exposure characterization. Therefore, efforts should
be made for harmonized QA/QC provisions while conserving the added
value of different workflows for exposure data for risk assessments.</dc:description>
          <dc:date>2026-09-15T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1021/acs.est.6c04347.s002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Comparing_Suspect_and_Nontargeted_Screening_Workflows_for_Perinatal_Chemical_Exposome_Analysis_A_European_Interlaboratory_Study_from_the_PARC-EU_Project/33791459</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
